Back to PRICE T ROWE ASSOCIATES INC /MD/ PRICE T ROWE ASSOCIATES INC /MD/

DNLIDNLI
Showing 8 of 28 quarters

Position history for PRICE T ROWE ASSOCIATES INC /MD/PRICE T ROWE ASSOCIATES INC /MD/'s holdings in DENALI THERAPEUTICS INC

PRICE T ROWE ASSOCIATES INC /MD/ holds 3.1M shares of DNLI (DENALI THERAPEUTICS INC), worth $80.7M as of 2026-Q2. The position was increased (+27.3% shares). DNLI represents 0.0% of PRICE T ROWE ASSOCIATES INC /MD/'s portfolio.

Current Value

$80.7M

Current Shares

3.1M

Total Value Change

-$2.9M

Total Shares Change

+266,354

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.1M
+27.3%
$80.7M0.0%$25.72
37
2026-Q1
Decreased
2.5M
-37.1%
$47.3M0.0%$20.02
0
2025-Q4
Decreased
3.9M
-14.3%
$64.7M0.0%$16.41
0
2025-Q3
Decreased
4.6M
-30.6%
$66.3M0.0%$14.52
0
2025-Q2
Increased
6.6M
+50.7%
$92.1M0.0%$14.10
41
2025-Q1
Increased
4.4M
+42.8%
$59.4M0.0%$14.78
40
2024-Q4
Increased
3.1M
+6.6%
$62.3M0.0%$20.24
31
2024-Q3
Increased
2.9M
+27.2%
$83.6M0.0%$29.43
37

Other major holders of DNLI: BAILLIE GIFFORD & CO, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used